Target-based drug discovery
CURRENT TRENDS IN DRUG DISCOVERY: TARGET IDENTIFICATION TO CLINICAL DEVELOPMENT OF THE DRUG
... the drug discovery process has been revolutionized with the involvement of some newer ...techniques. Target based drug design is more advantageous, time consuming and ...discovered)) ...
5
Quantum mechanics implementation in drug-design workflows: does it really help?
... the drug- discovery process is a trial-and-error ...the discovery of new drugs has always been the motivation for the industry to keep up the pace and keep abreast with the endless demand for ...the ...
14
Computational approaches: discovery of GTPase HRas as prospective drug target for 1,3-diazine scaffolds
... the target proteins based on reverse pharmacophore ...feasible target proteins for the developed compounds through reverse pharmacophore ...possible target of 1,3-diazine derivatives for their ...
13
Discovery 2: an interactive resource for the rational selection and comparison of putative drug target proteins in malaria
... The resource allows researchers to perform quick searches based on specific proteins, but to also perform mining and filtering of possible drug targets based on a series of molecular properties. ...
9
Kinetics for Drug Discovery: an industry-driven effort to target drug residence time
... TR-FRET based assay has been successfully applied to measure the kinetics of both labelled and unlabeled ligands at the histamine H1 receptor [46], gonadotropin-releasing hormone (GnRH) receptor [47] and the ...
37
DYNAMICS OF BIOINFORMATICS IN THE ARTIFICIAL DESIGNING OF DRUGS
... of drug design is to find a chemical compound that can fit to a specific cavity on a protein target both geometrically and ...a drug available to patients. The conventional drug design methods ...
9
Discovery: an interactive resource for the rational selection and comparison of putative drug target proteins in malaria
... wild-type enzyme, but also the mutant P. falciparum DHFR, while still retaining anti-malarial activity [35]. Plasmodium falciparum DHFR-TS was selected in the Dis- covery system by searching with the keyword dihydro- ...
8
A perspective on multi target drug discovery and design for complex diseases
... and Drug Administration; FGFR: fibroblast growth factor receptors; FMPA: N‑(furan‑2‑ylmethyl)‑N‑methylprop‑2‑yn‑1‑amine (a propargylamine inhibitor of MAO); GPCR: G‑protein coupled receptor; H3R: histone type 3 ...
14
Essential Gene Discovery in the Basidiomycete Cryptococcus neoformans for Antifungal Drug Target Prioritization
... In strain 2aBIO2E9, generated with biolistic transformation, the NAT insertion produced a 2,139-bp deletion that involved the 5= regions of two adjacent genes, the S. pombe ortholog asl1, not present in S. cerevisiae, ...
18
PROGNOSTIC BIOMARKERS IN TRIPLE NEGATIVE BREAST CANCER AS A POTENTIAL TARGET FOR FUTURE DRUG DISCOVERY
... Breast cancer is one of the most common malignant tumors among women, and it is a heterogeneous type of disease because of their therapy response. We can define its molecular subtypes by immunohistochemistry (IHC). ...
5
Decaprenyl-phosphoryl-ribose 2′-epimerase (DprE1): challenging target for antitubercular drug discovery
... extensively drug resistance Mycobacterium tuberculosis and affect Mtb in vitro in conjunction with rifampicin or ...cell- based phenotypic screens to reveal atoms with compo- nents of activity that give one ...
12
ROLE OF BIOINFORMATICS, CHEMOINFORMATICS AND PROTEOMIC IN BIOMARKER IDENTIFICATION AND DRUG TARGET VALIDATION IN DRUG DISCOVERY PROCESSES
... in Target Validation: Genomic, transcriptomic and proteomic technologies 29 are currently driving the pharmaceutical industry’s search for novel targets that will result in innovative ...that drug ...
13
Mycobacterial CYP121 as a target for anti TB drug discovery
... (multiple drug resistance) and more extremely resistant (excessive drug resistance and even total drug resistance) highlight the necessity of the development of new therapeutic ...new drug ...
10
Drug target ontology to classify and integrate drug discovery data
... biased target selection [1]. Although the drug target mechanism of action is not re- quired for FDA approval, a target-based mechanistic under- standing of diseases and drug ...
16
Biomarkers in Drug Discovery and Development: From Target Identification to Drug Marketing
... speed drug development Traditional dose range finding clinical trials in oncology escalated up to the maximum tolerated dose (MTD), which was the intended clinical dose for cytotoxic ...(OBD) based on ...
7
Lipoprotein biosynthesis as a target for anti Wolbachia treatment of filarial nematodes
... Results: Globomycin, a signal peptidase II (LspA) inhibitor, has activity against Gram-negative bacteria and a putative lspA gene has been identified from the Wolbachia genome of Brugia malayi (wBm). The amino acids ...
10
Scientometrics of drug discovery efforts: pain-related molecular targets
... Abstract: The aim of this study was to make a scientometric assessment of drug discovery efforts centered on pain-related molecular targets. The following scientometric indices were used: the popularity ...
12
What lies at the interface of regenerative medicine and developmental biology?
... polymer-based drug delivery systems to deliver two angiogenic factors – VEGFA and PDGFBB – with different dynamics (VEGFA fast; PDGFBB slow) in a defined spatial gradient in the same tissue produces much ...
7
New drug development process-Today: A review
... potential drug interactions, identifi- cation of new indication, evaluation of different formulations, to estimate incidence of adverse reactions, detect previously unknown ADRs and identity risk factor for ...The ...
10
Activity-based protein profiling
... resulting peptides are separated with liquid chromatography and measured using mass spectrometry (Li et al., 2013). The mea- sured peptides will allow the identification of the labelled pro- teins. The peptides are ...
10